BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 15586316)

  • 61. A program for managing weight gain associated with atypical antipsychotics.
    Vreeland B; Minsky S; Menza M; Rigassio Radler D; Roemheld-Hamm B; Stern R
    Psychiatr Serv; 2003 Aug; 54(8):1155-7. PubMed ID: 12883145
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Psychiatric medication induced obesity: an aetiologic review.
    Virk S; Schwartz TL; Jindal S; Nihalani N; Jones N
    Obes Rev; 2004 Aug; 5(3):167-70. PubMed ID: 15245385
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Qualitative descriptive study exploring schizophrenia and the everyday effect of medication-induced weight gain.
    Vandyk AD; Baker C
    Int J Ment Health Nurs; 2012 Aug; 21(4):349-57. PubMed ID: 22404848
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Mechanisms of weight gain induced by antipsychotic drugs.
    Baptista T
    J Clin Psychiatry; 2002 Mar; 63(3):245-6. PubMed ID: 11926725
    [No Abstract]   [Full Text] [Related]  

  • 65. Antipsychotic-induced weight gain: a review of the literature.
    Allison DB; Casey DE
    J Clin Psychiatry; 2001; 62 Suppl 7():22-31. PubMed ID: 11346192
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Atypical antipsychotic induced weight gain: pathophysiology and management.
    Ananth J; Venkatesh R; Burgoyne K; Gadasalli R; Binford R; Gunatilake S
    Ann Clin Psychiatry; 2004; 16(2):75-85. PubMed ID: 15328901
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Obesity in patients with severe mental illness: overview and management.
    McElroy SL
    J Clin Psychiatry; 2009; 70 Suppl 3():12-21. PubMed ID: 19570497
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Schizophrenia and neural transmission: an excess of analogical treatment?].
    Tassin JP
    Encephale; 1996 Oct; 22 Spec No 3():91-8. PubMed ID: 9036015
    [No Abstract]   [Full Text] [Related]  

  • 69. [Non-pharmacological interventions for weight gain in patients with schizophrenia taking antipsychotics].
    Attux C; Martini LC; Reis AF; Bressan RA
    Arq Bras Endocrinol Metabol; 2009 Jun; 53(4):391-8. PubMed ID: 19649375
    [TBL] [Abstract][Full Text] [Related]  

  • 70. What do people with schizophrenia think about weight management?
    Weissman EM; Moot DM; Essock SM
    Psychiatr Serv; 2006 May; 57(5):724-5. PubMed ID: 16675776
    [No Abstract]   [Full Text] [Related]  

  • 71. Reversal of antipsychotic-associated weight gain.
    O'Keefe CD; Noordsy DL; Liss TB; Weiss H
    J Clin Psychiatry; 2003 Aug; 64(8):907-12. PubMed ID: 12927005
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Antipsychotic-induced weight gain.
    Goudie AJ; Cooper GD; Halford JC
    Diabetes Obes Metab; 2005 Sep; 7(5):478-87. PubMed ID: 16050940
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Non-Pharmacological Interventions for the Prevention of Weight Gain in Schizophrenic Patients Treated with Antipsychotic Medication].
    Fink A; Cieslak S; Rosenbach F
    Psychiatr Prax; 2015 Oct; 42(7):359-69. PubMed ID: 26158719
    [TBL] [Abstract][Full Text] [Related]  

  • 74. An overview of obesity in children with psychiatric disorders taking atypical antipsychotics.
    Shin L; Bregman H; Frazier J; Noyes N
    Harv Rev Psychiatry; 2008; 16(2):69-79. PubMed ID: 18415880
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Weight gain and antipsychotic drug treatment].
    Patri E; Dantchev N; Martinez M
    Encephale; 2000; 26(6):93-7. PubMed ID: 11217543
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Clinical evaluation of a new therapeutic combination in the treatment of obesity].
    Turatti S; Netto GA
    Hospital (Rio J); 1971 Jan; 79(1):51-60. PubMed ID: 5316655
    [No Abstract]   [Full Text] [Related]  

  • 77. Pilot study of the efficacy of an educational programme to reduce weight, on overweight and obese patients with chronic stable schizophrenia.
    Iglesias-GarcĂ­a C; Toimil-Iglesias A; Alonso-Villa MJ
    J Psychiatr Ment Health Nurs; 2010 Nov; 17(9):849-51. PubMed ID: 21077409
    [No Abstract]   [Full Text] [Related]  

  • 78. Medication-induced weight gain and dyslipidemia in patients with schizophrenia.
    Fenton WS; Chavez MR
    Am J Psychiatry; 2006 Oct; 163(10):1697-704; quiz 1858-9. PubMed ID: 17012676
    [No Abstract]   [Full Text] [Related]  

  • 79. Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management.
    Manu P; Dima L; Shulman M; Vancampfort D; De Hert M; Correll CU
    Acta Psychiatr Scand; 2015 Aug; 132(2):97-108. PubMed ID: 26016380
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The genetic association of FTO variants with metabolic traits in patients with schizophrenia may be modified by antipsychotics.
    Huang MC; Kao CF; Chiu CC; Kuo PH; Chen PY; Lu ML; Chen CH
    J Clin Psychopharmacol; 2014 Feb; 34(1):162-5. PubMed ID: 24346748
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.